GSK vs LMAT · P/E 13, $103.31B cap vs P/E 35, rev $136.9M
GlaxoSmithKline PLC ADR (GSK) versus LeMaitre Vascular Inc (LMAT) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
LeMaitre Vascular Inc (LMAT) is a medical instruments & supplies company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported LMAT revenue for 2026-06-30 was $136.9M. Net income was $32.7M. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
Not investment advice. Open the GSK and LMAT stock pages for the full models.
Not investment advice.